Exparel 1.3% 20ML 10S
Ended Awarded
- Contract number
- SPE2DR26FBTAL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,327
Award facts
- Contract value 100% obligated
- $20,326.88 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,326.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 1.3% in 20mL quantities (10 units). The delivery order, issued without a set-aside designation, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain and has demonstrated substantial contracting activity with the Defense Logistics Agency's Medical Supply Chain division, delivering a comprehensive portfolio of pharmaceuticals and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical supplies to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with a completion date of December 31, 2036, and includes a 30-month base period with three 30-month option periods. EXPAREL, a specialty surgical pharmaceutical product, exemplifies the breadth of pharmaceutical offerings DMS Pharmaceutical Group supplies under this strategic partnership, positioning the company as a key regional prime vendor contractor supporting the Department of Defense's global military medical system requirements.
Quick answers
Who was awarded contract SPE2DR26FBTAL?
SPE2DR26FBTAL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FBTAL worth?
The government has obligated $20,327 on SPE2DR26FBTAL.
Is contract SPE2DR26FBTAL an order under another contract?
Yes. SPE2DR26FBTAL is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTAL competed?
The extent of competition for SPE2DR26FBTAL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award